Drug Enforcement Administration January 2013 – Federal Register Recent Federal Regulation Documents

Manufacturer of Controlled Substances; Notice of Application; PCAS-Nanosyn, LLC
Document Number: 2013-01864
Type: Notice
Date: 2013-01-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Alkermes Gainesville, LLC
Document Number: 2013-01837
Type: Notice
Date: 2013-01-29
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Mylan Technologies, Inc.
Document Number: 2013-01835
Type: Notice
Date: 2013-01-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Johnson Matthey, Inc.
Document Number: 2013-01603
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Noramco, Inc.
Document Number: 2013-01600
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration; Morton Grove Pharmaceuticals
Document Number: 2013-01592
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application; Siegfried (USA)
Document Number: 2013-01591
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration; Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2013-01588
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Cerilliant Corporation
Document Number: 2013-01556
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; R & D Systems, Inc.
Document Number: 2013-01554
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Myoderm
Document Number: 2013-01540
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2013-01536
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Chemic Laboratories, Inc.
Document Number: 2013-01535
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Ampac Fine Chemicals, LLC
Document Number: 2013-01534
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Cerilliant Corporation
Document Number: 2013-01533
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Fisher Clinical Services, Inc.
Document Number: 2013-01532
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Chattem Chemicals, Inc.
Document Number: 2013-01530
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Exempt Chemical Preparations Under the Controlled Substances Act
Document Number: 2013-01133
Type: Notice
Date: 2013-01-22
Agency: Drug Enforcement Administration, Department of Justice
The applications for exempt chemical preparations received by DEA between June 12, 2011, and June 30, 2012, as listed below, were accepted for filing and have been approved or denied as indicated.
Establishment of Drug Codes for 26 Substances
Document Number: 2012-31698
Type: Rule
Date: 2013-01-04
Agency: Drug Enforcement Administration, Department of Justice
On July 9, 2012, the President signed into law the Synthetic Drug Abuse Prevention Act of 2012 (SDAPA). SDAPA amends the Controlled Substances Act by placing 26 substances in Schedule I. DEA is publishing this rule to establish drug codes for these 26 substances, and to make technical and conforming amendments in accordance with SDAPA.